FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Heritage Pharmaceuticals Desmopressin Acetate Tablets 0 Recall

Desmopressin Acetate Tablets 0

Heritage Pharmaceuticals Inc · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Dec 7, 2022
Recall ID
D-0072-2023
Check your lot numberHow we source this data

Summary

Heritage Pharmaceuticals recalled Desmopressin Acetate Tablets 0 starting Nov 23, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0072-2023 on Dec 7, 2022. Reason: Subpotent Drug. Status: Terminated.

Why it was recalled

Subpotent Drug

Product description

Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01

Lot numbers, UPCs & expiration codes

Lot #: 220440A, Exp. Date 05/2024

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0072-2023
Classification
Class II
Status
Terminated
Recall initiated
Nov 23, 2022
FDA report date
Dec 7, 2022
Quantity
13805 Bottles each containing 100 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Heritage Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0072-2023, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
91171
Address
1 Tower Center Blvd Ste 1700
Code information
Lot #: 220440A, Exp. Date 05/2024
Postal code
08816-1145
Report date
Dec 7, 2022
Product type
Drugs
Recall number
D-0072-2023
Classification
Class II
Recalling firm
Heritage Pharmaceuticals Inc
Product quantity
13805 Bottles each containing 100 tablets
Termination date
Dec 13, 2023
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Desmopressin Acetate Tablets 0.2mg, 100-count bottles, RX Only, Distributed by: Avet Pharmaceuticals Inc. East Brunswick, NJ 08816, NDC 23155-490-01
Distribution pattern
Nationwide within the United States
Recall initiation date
Nov 23, 2022
Initial firm notification
Letter
Center classification date
Nov 29, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0072-2023, published Dec 7, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls